Can Edwards Lifesciences Corp. Capitalize on This Opportunity?

Edwards wins a legal ruling against Medtronic, but while momentum's behind this stock, don't be overconfident.

Apr 16, 2014 at 9:32AM

Innovative med tech stock Edwards Lifesciences (NYSE:EW) has been one of the most exciting stocks to watch in the medical device industry lately. Shares have fallen over the past year, but Edwards' battle to secure dominance in the transcatheter aortic heart valve market, particularly in the U.S., where it won the first approval of a device of its kind for its Sapien heart valve, has been an intense battle. On the other side of the fight, rival Medtronic (NYSE:MDT) has remained hot on Edwards' heels, and this year has looked primed to knock down the company's leadership in the U.S. by securing Food and Drug Administration approval for its own competing CoreValve heart valve.

But not so fast, says Edwards. The company on Monday won a legal victory against the CoreValve after a U.S. court placed an injunction against Medtronic's device's sales. While Medtronic answered with a motion to stay that injunction, it will need to file an appeal to continue its momentum in the U.S. market -- and Edwards has one critical time to cement its place as the American leader in this niche before Medtronic and other companies can chip away at its market share.

Can Edwards' stock rally and the Sapien keep sales growth churning higher? In the video below, Motley Fool contributor Dan Carroll takes you through all you need to know regarding the latest in the battle between these two fierce med tech rivals and whether Edwards' stock can emerge as a long-term winner for your portfolio.

Don't miss out on the potential of The Motley Fool's top stock in 2014
Good stocks like Medtronic can boost a portfolio's returns, but the smartest investors know a key secret to market success: There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Dan Carroll has no position in any stocks mentioned. The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers